543 results on '"Ullrich, Evelyn"'
Search Results
2. CD16+ as predictive marker for early relapse in aggressive B-NHL/DLBCL patients
3. Manufacturing of primary CAR-NK cells in an automated system for the treatment of acute myeloid leukemia
4. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
5. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers
6. Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD
7. Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
8. Flares of acute graft-versus-host disease: a Mount Sinai Acute GVHD International Consortium analysis
9. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units
10. Differences in Acute Graft-Versus-Host Disease (GVHD) Severity and Its Outcomes Between Black and White Patients
11. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD
12. Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use
13. Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia
14. Disturbance in cerebral blood microcirculation and hypoxic-ischemic microenvironment are associated with the development of brain metastasis
15. Unleashing the power of NK cells in anticancer immunotherapy
16. COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view
17. Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
18. The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome
19. Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy
20. Empowering virus-free CAR immune cell therapies
21. Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany
22. Langzeitnachsorge
23. Autoreninnen und Autoren
24. Immune profiling and functional analysis of NK and T cells in ataxia telangiectasia.
25. Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia
26. Correction: Translatome proteomics identifies autophagy as a resistance mechanism to on-target FLT3 inhibitors in acute myeloid leukemia
27. Flares of Acute Graft-Versus-Host Disease (GVHD): A Mount Sinai Acute GVHD International Consortium (MAGIC) Analysis
28. The Mount Sinai Acute Gvhd International Consortium (MAGIC) Model: An Integrated Clinical and Biomarker Grading System for Acute Graft-Versus-Host Disease (GVHD)
29. Cover Image, Volume 44, Issue 1
30. Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
31. Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer
32. Cytokine-responsive T- and NK-cells portray SARS-CoV-2 vaccine-responders and infection in multiple myeloma patients
33. Editorial: Women in cancer immunity and immunotherapy.
34. Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy
35. Co-Expression of an IL-15 Superagonist Facilitates Self-Enrichment of GD2-Targeted CAR-NK Cells and Mediates Potent Cell Killing in the Absence of IL-2
36. Editorial: Translating NK cell scientific research to clinical product manufacturing
37. ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma
38. PB2070: IMMUNE RESPONSES AFTER SARS-COV-2 MRNA-VACCINATION AND INFECTION AT SINGLE CELL RESOLUTION IN PATIENTS WITH MULTIPLE MYELOMA
39. P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
40. The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
41. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma
42. Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer.
43. Kapitel 22 - Langzeitnachsorge
44. BATF-dependent IL-7[R.sup.hi]GM-[CSF.sup.+] T cells control intestinal graft-versus-host disease
45. Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
46. Supplementary Figures S1-S7 from Dendritic Cell Vaccination with Xenogenic Polypeptide Hormone Induces Tumor Rejection in Neuroendocrine Cancer
47. Supplementary Figure 1 from Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells
48. Supplementary Table 2 from Cancer-Induced Immunosuppression: IL-18–Elicited Immunoablative NK Cells
49. Supplementary Figure 1 from IL-18 Induces PD-1–Dependent Immunosuppression in Cancer
50. Data from The Dendritic Cell–like Functions of IFN-Producing Killer Dendritic Cells Reside in the CD11b+ Subset and Are Licensed by Tumor Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.